Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Yongchao,Cai

第一单位： Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University School of Medicine, Shanghai, 200123, P. R. China.

作者： Yongchao,Cai ^[1] ; Yong,Fu ^[2] ; Changcheng,Liu ^[3] ; Xicheng,Wang ^[4] ; Pu,You ^[1] ; Xiuhua,Li ^[2] ; Yanxiang,Song ^[3] ; Xiaolan,Mu ^[1] ; Ting,Fang ^[2] ; Yang,Yang ^[3] ; Yuying,Gu ^[5] ; Haibin,Zhang ^[1] ; Zhiying,He ^[2]

作者单位： Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University School of Medicine, Shanghai, 200123, P. R. China. ^[1] Shanghai Engineering Research Center of Stem Cells Translational Medicine, Shanghai, 200335, P. R. China. ^[2] Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai, 200120, P. R. China. ^[3] Department of Liver Surgery V, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, P. R. China. ^[4] Institute of Brain-Intelligence Science and Technology, Zhangjiang Laboratory & Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai, 201210, P. R. China. ^[5] Department of cardiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, P.R. China. ^[6] Department of Liver Surgery V, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, P. R. China. drzhanghb@163.com. ^[7] Institute for Regenerative Medicine, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University School of Medicine, Shanghai, 200123, P. R. China. zyhe@tongji.edu.cn. ^[8] Shanghai Engineering Research Center of Stem Cells Translational Medicine, Shanghai, 200335, P. R. China. zyhe@tongji.edu.cn. ^[9] Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai, 200120, P. R. China. zyhe@tongji.edu.cn. ^[10]